Back to search

Netherlands· NL-d51f980fac4e

Imcivree 10 mg/ml oplossing voor injectie

A setmelanotide product containing setmelanotideacetaat, registered in Netherlands by Rhythm Pharmaceuticals Netherlands B.V.. The same ATC class is registered in 12 of our 19 countries.

ATC A08AA12

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedImcivree 10 mg/ml oplossing voor inje…ATCA08AA12REGISTER NO.NL-d51f980fac4ePACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Setmelanotide is registered in 12 of 19 countries.

Countries holding a registration under ATC A08AA12 (setmelanotide), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 8 of them publish a price we can compare per daily dose

Setmelanotide · ATC A08AA12

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
SETMELANOTIDEACETAAT
Manufacturer
Rhythm Pharmaceuticals Netherlands B.V.
Country
Netherlands (NL)
ATC code
A08AA12
ATC class
Setmelanotide
Defined daily dose
1.5 mg, P
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/21/1564

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5cac5fd5-d3c6-461e-a0e5-f4de9e7a9f85
GET /v1/drugs/5cac5fd5-d3c6-461e-a0e5-f4de9e7a9f85?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": "Subcutaan gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/imcivree-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Setmelanotide",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp126987",
  "excipients": [
    "BENZYLALCOHOL (E 1519)",
    "CARMELLOSE NATRIUM (E 466)",
    "DINATRIUMEDETAAT 2-WATER",
    "FENOL",
    "MANNITOL (D-) (E 421)",
    "N-(CARBONYL-METHOXYPOLYETHYLEENGLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE NATRIUM",
    "NATRIUMHYDROXIDE (E 524)",
    "STIKSTOF (HEAD SPACE) (E 941)",
    "WATER VOOR INJECTIE",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "SETMELANOTIDEACETAAT"
  ],
  "leaflet_url": null,
  "authorised_at": "2021/07/16",
  "procedure_number": "EMEA/H/C/005089",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/21/1564",
  "additional_monitoring": "N"
}

See everything about setmelanotide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.